Basler Kantonalbank Share Price

Certificat

BIJBKB

CH1261612852

Market Closed - Swiss Exchange 08:50:00 12/06/2024 pm IST
101 CHF +0.09% Intraday chart for Basler Kantonalbank
1 month+0.81%
3 months+3.25%
Date Price Change

Delayed Quote Swiss Exchange

Last update June 12, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Basler Kantonalbank
BIJBKB
ISINCH1261612852
Date issued 04/10/2023
Strike 244 CHF
Maturity 04/04/2025 (293 Days)
Parity 0.24 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101 CHF
Lowest since issue 90.2 CHF
Spread 8.1 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
247.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+12.30%
Consensus
  1. Stock Market
  2. Certificates
  3. BIJBKB Certificat